HEADER TRANSCRIPTION 19-MAY-16 2NDF TITLE SOLUTION NMR STRUCTURES OF AF9 YEATS DOMAIN IN COMPLEX WITH HISTON H3 TITLE 2 ACETYLATION AT K18 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN AF-9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: YEATS DOMAIN RESIDUES 1-138; COMPND 5 SYNONYM: ALL1-FUSED GENE FROM CHROMOSOME 9 PROTEIN, MYELOID/LYMPHOID COMPND 6 OR MIXED-LINEAGE LEUKEMIA TRANSLOCATED TO CHROMOSOME 3 PROTEIN, YEATS COMPND 7 DOMAIN-CONTAINING PROTEIN 3; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: HISTONE H3 PEPTIDE; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MLLT3, AF9, YEATS3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: RIL STRAIN CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: BL21(DE3); SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES KEYWDS HISTONE, CROTONYLATION, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.ZENG,M.ZHOU REVDAT 2 21-SEP-16 2NDF 1 JRNL REVDAT 1 07-SEP-16 2NDF 0 JRNL AUTH Q.ZHANG,L.ZENG,C.ZHAO,Y.JU,T.KONUMA,M.M.ZHOU JRNL TITL STRUCTURAL INSIGHTS INTO HISTONE CROTONYL-LYSINE RECOGNITION JRNL TITL 2 BY THE AF9 YEATS DOMAIN. JRNL REF STRUCTURE V. 24 1606 2016 JRNL REFN ISSN 0969-2126 JRNL PMID 27545619 JRNL DOI 10.1016/J.STR.2016.05.023 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.3, TALOS TALOSN, TALOSPLUS, CNS 1.2 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), CORNILESCU, REMARK 3 DELAGLIO AND BAX (TALOS), BRUNGER, ADAMS, CLORE, REMARK 3 GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NDF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-MAY-16. REMARK 100 THE RCSB ID CODE IS RCSB104725. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 10 MM SODIUM PHOSPHATE, 500 MM REMARK 210 SODIUM CHLORIDE, 2 MM EDTA, 2 MM REMARK 210 [U-100% 2H] DTT, 90% H2O/10% D2O; REMARK 210 10 MM SODIUM PHOSPHATE, 500 MM REMARK 210 SODIUM CHLORIDE, 2 MM EDTA, 2 MM REMARK 210 [U-100% 2H] DTT, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HNCO; 3D 1H-15N REMARK 210 NOESY; 3D 1H-15N TOCSY; 3D 1H-13C REMARK 210 NOESY ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 3D FILTERED 1H-13C REMARK 210 NOESY ALIPHATIC; 3D FILTERED 1H- REMARK 210 13C NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 900 MHZ; 600 MHZ; 500 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 7.1, NMRVIEW 5.04 C- REMARK 210 VERSION, CNS 1.2, TOPSPIN REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING, TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 26 156.04 -47.72 REMARK 500 1 ARG A 64 80.87 60.50 REMARK 500 1 PRO A 72 -167.06 -30.22 REMARK 500 1 PRO A 73 121.00 -32.19 REMARK 500 1 TYR A 74 91.73 -65.90 REMARK 500 1 GLU A 96 -152.95 -99.60 REMARK 500 1 GLU A 97 152.37 -32.43 REMARK 500 1 GLU A 112 100.81 -54.75 REMARK 500 1 PRO A 115 127.51 -27.64 REMARK 500 1 PRO A 116 -179.11 -66.98 REMARK 500 2 HIS A 3 38.84 -85.72 REMARK 500 2 GLU A 43 70.18 58.70 REMARK 500 2 HIS A 44 -11.12 71.74 REMARK 500 2 PRO A 72 -178.53 -32.71 REMARK 500 2 PRO A 73 119.55 -28.29 REMARK 500 2 TYR A 74 98.66 -60.10 REMARK 500 2 GLU A 96 -153.12 -100.62 REMARK 500 2 GLU A 97 152.74 -29.56 REMARK 500 2 PRO A 98 122.46 -32.89 REMARK 500 2 ASN A 129 67.51 62.43 REMARK 500 2 PRO B 216 161.55 -48.82 REMARK 500 2 GLN B 219 -56.80 71.51 REMARK 500 3 PRO A 26 154.79 -49.28 REMARK 500 3 HIS A 44 -6.76 75.51 REMARK 500 3 ARG A 64 73.80 61.64 REMARK 500 3 PRO A 72 178.37 -31.17 REMARK 500 3 PRO A 73 121.99 -26.32 REMARK 500 3 TYR A 74 91.53 -62.21 REMARK 500 3 TYR A 81 -17.48 -144.51 REMARK 500 3 GLU A 96 -155.71 -100.08 REMARK 500 3 GLU A 97 149.48 -32.50 REMARK 500 3 PRO A 98 125.72 -30.22 REMARK 500 3 GLU A 112 98.93 -63.37 REMARK 500 3 PRO A 115 113.04 -24.49 REMARK 500 3 PRO A 116 -179.54 -55.48 REMARK 500 3 PRO B 216 176.17 -51.90 REMARK 500 3 ALY B 218 46.73 -109.11 REMARK 500 3 GLN B 219 -52.10 -137.25 REMARK 500 3 THR B 222 17.44 -143.17 REMARK 500 4 HIS A 3 30.04 -141.33 REMARK 500 4 GLN A 48 -3.69 -59.66 REMARK 500 4 GLU A 52 -60.24 -102.62 REMARK 500 4 PRO A 72 178.57 -31.13 REMARK 500 4 PRO A 73 124.24 -29.64 REMARK 500 4 TYR A 74 93.94 -61.87 REMARK 500 4 GLU A 96 -153.92 -100.29 REMARK 500 4 GLU A 97 150.19 -27.07 REMARK 500 4 PRO A 98 126.43 -32.50 REMARK 500 4 GLN B 219 46.45 -84.52 REMARK 500 4 ALA B 221 97.74 -161.35 REMARK 500 REMARK 500 THIS ENTRY HAS 250 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 72 PRO A 73 5 -149.52 REMARK 500 PRO A 72 PRO A 73 12 -147.41 REMARK 500 PRO A 72 PRO A 73 16 -149.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 26059 RELATED DB: BMRB REMARK 900 RELATED ID: 2NDG RELATED DB: PDB DBREF 2NDF A 4 141 UNP P42568 AF9_HUMAN 1 138 DBREF 2NDF B 212 224 PDB 2NDF 2NDF 212 224 SEQADV 2NDF GLY A 1 UNP P42568 EXPRESSION TAG SEQADV 2NDF SER A 2 UNP P42568 EXPRESSION TAG SEQADV 2NDF HIS A 3 UNP P42568 EXPRESSION TAG SEQRES 1 A 141 GLY SER HIS MET ALA SER SER CYS ALA VAL GLN VAL LYS SEQRES 2 A 141 LEU GLU LEU GLY HIS ARG ALA GLN VAL ARG LYS LYS PRO SEQRES 3 A 141 THR VAL GLU GLY PHE THR HIS ASP TRP MET VAL PHE VAL SEQRES 4 A 141 ARG GLY PRO GLU HIS SER ASN ILE GLN HIS PHE VAL GLU SEQRES 5 A 141 LYS VAL VAL PHE HIS LEU HIS GLU SER PHE PRO ARG PRO SEQRES 6 A 141 LYS ARG VAL CYS LYS ASP PRO PRO TYR LYS VAL GLU GLU SEQRES 7 A 141 SER GLY TYR ALA GLY PHE ILE LEU PRO ILE GLU VAL TYR SEQRES 8 A 141 PHE LYS ASN LYS GLU GLU PRO ARG LYS VAL ARG PHE ASP SEQRES 9 A 141 TYR ASP LEU PHE LEU HIS LEU GLU GLY HIS PRO PRO VAL SEQRES 10 A 141 ASN HIS LEU ARG CYS GLU LYS LEU THR PHE ASN ASN PRO SEQRES 11 A 141 THR GLU ASP PHE ARG ARG LYS LEU LEU LYS ALA SEQRES 1 B 13 GLY GLY LYS ALA PRO ARG ALY GLN LEU ALA THR LYS ALA MODRES 2NDF ALY B 218 LYS N(6)-ACETYLLYSINE HET ALY B 218 26 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 2 ALY C8 H16 N2 O3 HELIX 1 1 GLY A 41 SER A 45 5 5 HELIX 2 2 THR A 131 ALA A 141 1 11 SHEET 1 A 4 TYR A 74 GLY A 80 0 SHEET 2 A 4 HIS A 33 ARG A 40 -1 N HIS A 33 O GLY A 80 SHEET 3 A 4 ALA A 9 VAL A 22 -1 N GLN A 21 O ASP A 34 SHEET 4 A 4 VAL A 117 HIS A 119 -1 O VAL A 117 N ALA A 20 SHEET 1 B 4 TYR A 74 GLY A 80 0 SHEET 2 B 4 HIS A 33 ARG A 40 -1 N HIS A 33 O GLY A 80 SHEET 3 B 4 ALA A 9 VAL A 22 -1 N GLN A 21 O ASP A 34 SHEET 4 B 4 CYS A 122 ASN A 128 -1 O GLU A 123 N LEU A 14 SHEET 1 C 4 LYS A 66 CYS A 69 0 SHEET 2 C 4 VAL A 51 HIS A 57 -1 N VAL A 54 O CYS A 69 SHEET 3 C 4 PHE A 84 PHE A 92 -1 O TYR A 91 N LYS A 53 SHEET 4 C 4 LYS A 100 LEU A 107 -1 O TYR A 105 N LEU A 86 LINK C ARG B 217 N ALY B 218 1555 1555 1.32 LINK C ALY B 218 N GLN B 219 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20